Renal Osteodystrophy
19
2
2
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.5%
2 terminated out of 19 trials
83.3%
-3.2% vs benchmark
16%
3 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (19)
Precision Medicine Approaches to Renal Osteodystrophy
Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function
The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients
The Effect of Etelcalcetide on CKD-MBD
Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)
Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
Renal Osteodystrophy: A Fresh Approach
Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
Low Magnitude Mechanical Stimuli Effects on Bone Structure in ESRD
Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients
12-month Study of AMG 073 in Renal Osteodystrophy
Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients
Regulation of Bone Formation in Renal Osteodystrophy
Osteopenia and Renal Osteodystrophy: Evaluation and Management
Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis